TB or Not TB, Is That the Question? 2021
DOI: 10.1136/thorax-2020-btsabstracts.304
|View full text |Cite
|
Sign up to set email alerts
|

P159 Monitoring prolongation of QT interval in patients with multidrug-resistant tuberculosis and non-tuberculous mycobacterium using mobile health device AliveCor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…15 Chapter 4 Systematic review results t he literature searches of bibliographic databases conducted for this EVA systematic review, including additional scoping searches conducted to identify costs and cost-effectiveness studies, identified 8505 unique references. After initial screening of titles and abstracts, 28 references were considered to be potentially relevant and ordered for full paper screening; of these 10 publications, 26,31,34,37,[39][40][41][42][43] relating to six studies, were included in the review. A further three publications, one provided by NICE/ Specialist Committee Members (SCMs) 14 and two provided by the manufacturer of KardiaMobile 6L, AliveCor, 51,52 were assessed and included in the review.…”
Section: Methods Of Analysis/synthesismentioning
confidence: 99%
See 2 more Smart Citations
“…15 Chapter 4 Systematic review results t he literature searches of bibliographic databases conducted for this EVA systematic review, including additional scoping searches conducted to identify costs and cost-effectiveness studies, identified 8505 unique references. After initial screening of titles and abstracts, 28 references were considered to be potentially relevant and ordered for full paper screening; of these 10 publications, 26,31,34,37,[39][40][41][42][43] relating to six studies, were included in the review. A further three publications, one provided by NICE/ Specialist Committee Members (SCMs) 14 and two provided by the manufacturer of KardiaMobile 6L, AliveCor, 51,52 were assessed and included in the review.…”
Section: Methods Of Analysis/synthesismentioning
confidence: 99%
“…Based on the searches and inclusion screening described above, 13 publications, 14,26,31,34,37,[39][40][41][42][43]51,52 relating to 8 studies, and 2 additional unpublished reports, 53,54 were included in this review; the results section of this report cites studies using the primary publication only.…”
Section: Overview Of Included Studiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Relatively few studies have investigated the six-lead device version. One small study showed the six-lead ACKM device underestimated QTc in twelve of thirteen patients with multidrug-resistant tuberculosis by a mean difference of 3% [11]. Pilot data has also shown good agreement of QTc, PR, and QRS intervals between the six-lead device and a standard twelve-lead ECG in young healthy athletes [12], however, there is no information on the accuracy of the device in a pediatric population…”
Section: Introductionmentioning
confidence: 99%